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Recently, an alternative theory concerning the method by which
olfactory proteins are activated has garnered attention. This the-
ory proposes that the activation of olfactory G protein-coupled
receptors occurs by an inelastic electron tunneling mechanism
that is mediated through the presence of an agonist with an
appropriate vibrational state to accept the inelastic portion of
the tunneling electron’s energy. In a recent series of papers, some
suggestive theoretical evidence has been offered that this the-
ory may be applied to nonolfactory G protein-coupled recep-
tors (GPCRs), including those associated with the central ner-
vous system (CNS). [Chee HK, June OS (2013) Genomics Inform
11(4):282–288; Chee HK, et al. (2015) FEBS Lett 589(4):548–552;
Oh SJ (2012) Genomics Inform 10(2):128–132]. Herein, we test the
viability of this idea, both by receptor affinity and receptor acti-
vation measured by calcium flux. This test was performed using
a pair of well-characterized agonists for members of the 5-HT2
class of serotonin receptors, 2,5-dimethoxy-4-iodoamphetamine
(DOI) and N,N-dimethyllysergamide (DAM-57), and their respec-
tive deuterated isotopologues. No evidence was found that selec-
tive deuteration affected either the binding affinity or the acti-
vation by the selected ligands for the examined members of the
5-HT2 receptor class.
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O lfaction—and other chemo-sensitive sensory processes—isan important information-gathering technique for organ-
isms of many clades and kingdoms. Specifically, human olfaction
is known to occur by activation of olfactory receptors (ORs)—
a subclass of G protein-coupled receptors (GPCRs)—located
within the nasal epithelium and mediating responses within the
olfactory bulb, where it is encoded and conveys information to
the amygdala, the orbitofrontal cortex, and the hippocampus
(1, 2). The discovery and the cloning of ORs led to the joint
2004 Nobel Prize in Physiology and Medicine to Richard Axel
and Linda Buck. (3) GPCRs are 7-helical transmembrane pro-
teins, facilitating communication from extracellular ligand sig-
nals to the cellular interior through activation of (interior) G
proteins, while maintaining the integrity of the membrane (4).
GPCRs are activated by an appropriate agonist moving into the
protein’s orthosteric binding site, resulting in a conformational
change within the helical bundle. This structural change leads to
altered conformations of the intracellular loops that couple to
appropriate signaling molecules within the cell, e.g., G proteins.
A recent series of papers has experimentally determined acti-
vated/inactivated states through isotopic-tagged receptors with
NMR spectroscopy (5–7). An additional work used molecular
dynamics to provide structural insights into how the agonist may
assist the interchange between conformations through several
proposed peptide sidechain pathways by examining the struc-
tures of the activated and inactivated µ-opioid receptor (8).
Additionally, photon-induced conformational changes in light-
sensitive proteins have also been observed (9, 10).
Recently, an iteration of the vibrational theory of olfaction
(VTO)—suggested and advocated by Luca Turin (11, 12)—
has arisen and has gained both supporters (13–16) and detrac-
tors (17, 18); the novelty of this incarnation of the VTO is
ascribable to its nonthermal- and nonphoton-based mechanism.
Turin’s theory is a contemporary reincarnation of the more clas-
sical theory proposed by Dyson (19), Wright (20), and Wright
and Serenius (21), where the activation of the olfactory recep-
tor is performed—or sensitive to—the molecular vibrations of
the olfactant. Dyson suggested that the molecular vibrations
of the agonist were exactly responsible for the activation of
the protein. These vibrations were entirely thermally excited,
as no mechanism for photoexcitation is available within the
body. The modern incarnation of this theory suggests that the
OR behaves as an electron-tunneling (ET) junction. Hypothet-
ically, this electron transfer instigates the conformation change
of the olfactory GPCR, leading to the intracellular signal cas-
cade. This theory both is contentious and lacks direct at-receptor
evidence. Several of the proposed tests for this theory, includ-
ing odor mixing, have been addressed to disprove this theory
through controlled sensory tests (13, 15). Additionally, more
modern examinations of this theory with both humans and
insect subjects have provided mixed and controversial results.
(14, 16–18, 22–24).
There have been several tests of the previous iterations of the
VTO, including odor blending (25, 26) and isotope exchange (20,
27–30); each of these methods—odor blending (11, 18) and iso-
tope exchange (11, 31)—has been used to evaluate the modern
VTO. Initial justifications of the VTO correlated characteristics
of the vibrational spectra with olfactory perception (12), contin-
ued within ORs (32), and expanded into non-OR GPCRs (33–
36). Isotope exchange—which provides the ability to alter the
vibrations of a molecule while maintaining its chemistry—may
manifest itself as an alteration of either the intensity or the qual-
ity of the scent. Isotope exchange tests of the VTO focused on
1H→2H exchange, although 13C exchange has been suggested
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Fig. 1. (A) Structure of the (R)-DOI molecule. In blue text, the atomic
indexes for some specific sidechain hydrogen atoms initially considered
for deuteration are shown. Additional sites considered for deuteration are
the hydrogens of the two methoxy groups. (B) Structure of the DAM-
57 molecule. In blue text, each methyl amide carbon where deuteration
exchange was undertaken is denoted as either carbon “a” or “b.”
(37). Unfortunately, measuring either quality or intensity
changes by sensory studies has presented itself as inconclusive
and difficult to quantify.
Recently, several recent studies—both in vitro and in vivo—
have been conducted at a more physiological level. Block et al.
(17) studied the activation of several ORs (importantly,
OR5AN1 and MOR244-3) by both muscone and cyclopen-
tadecanone; neither receptor displayed a significant differen-
tial response to isotopologues of the musk odorants, suggest-
ing failure of the VTO at mammalian ORs. However, criticism
of this work has arisen on grounds of lacking the in situ envi-
ronment (odorant binding proteins, cofactors, etc.) and possibly
being too specific with respect to the repertoire of examined ORs
(23, 24, 38, 39). Supporting previous behavioral studies (14, 16),
Drimyl et al. (23) and Paoli et al. (24) studied direct electro-
physical responses induced by odorant detection at the antennae
and glomeral lobe of several Drosophila species and Apis mel-
lifera, respectively. These findings show unique spatial–temporal
responses with respect to families of isotopologues. Two things
should be further noted with respect to these in situ insect stud-
ies: (i) Despite attempts at compensation, these results may not
be entirely independent of perireceptor effects (including trans-
port, enzymes, and extracellular vestibule). (ii) Insect ORs are
ionotropic receptors (IRs) and not GPCRs; each class of recep-
tors (GPCRs vs. IRs) shows specific evolutionary benefits (broad
responsiveness vs. speed of detection and processing) (40, 41).
Herein, we exploit the fact that ORs are a subclass of the
broader GPCR family with highly conserved sequences and
structural motifs. The nonexceptionalism of ORs within the
broader class of GPCRs was previously discussed within the con-
text of the VTO (18) and is highlighted by Barwich (42), who
asserts ORs are a model system for the GPCRs within neuro-
biology. Furthermore, ORs maintain up to 40% genetic similar-
ity with rhodopsin (43). Additionally, ORs appear within areas
of mammalian corpus that have no olfactory capacity (44–55).
We therefore hypothesize that due to functional and morpholog-
ical similarities, if ORs are activated through an ET mechanism,
other GPCRs share the same fundamental mechanism. Examina-
tion of another (better characterized) GPCR subclass may pro-
vide insight into the possibility of the proposed ET mechanism.
The serotonin 5-HT2 receptor class, notably a primary target
for hallucinogenic compounds, was selected as the main test for
the contemporary VTO. (R)-2,5-dimethoxy-4-iodoamphetamine
(R-DOI) is a well-characterized agonist for the serotonin 5-HT2A
receptor used as a standard ligand for studying the pharmacol-
ogy of 5-HT2A receptors and is widely used as a radioligand
to measure expression and affinity of ligands at 5-HT2A recep-
tors, particularly in brain tissues. (R)-DOI is reported to have
psychedelic effects somewhat similar to those of lysergic acid
diethylamide (LSD) (56). A quintessential hallucinogenic ligand
for the 5-HT2A receptor is LSD; a highly related (non-Schedule
1) molecule is generated by substituting the diethyl amide with a
dimethyl amide, creating N,N-dimethyllysergamide (DAM-57).
DAM-57 is an assumed serotonergic psychedelic with limited
hallucinogenic capacity and very mild autonomic stimulation in
humans at dosages of ∼100µg (57).
The organization of this paper is as follows: Theoretical Pre-
dictions gives a brief explanation of the theoretical predictions
for (R)-DOI at members of the 5-HT2 serotonin receptor class
according to Turin’s theory, while making direct reference to
a previous work concerning similar predictions for DAM-57;
Experimental Procedures briefly introduces methods of experi-
mental analysis for determining affinity; Results and Discussion
provides a discussion of the experimental results and a compar-
ison with theoretical predictions; and finally, in Conclusion we
provide concluding remarks.
Theoretical Predictions
Turin—within the contemporary VTO—hypothesized that the
active site of the GPCR [specifically an OR, although later works
considered generalizing this hypothesis (18, 36, 58)] acts as an
ET junction (11). According to the theory, an electron emerges
from a donation site—likely a metal atom acting as a cofac-
tor (11, 31), redox chemistry (59), or peptide sidechain (11, 60)
capable of oxidation—and traverses the active site to an accep-
tor site, which is likely a specific motif or residue sidechain. As
the electron traverses the active site, it may undertake several
paths: (i) elastic tunneling, where no energy is lost or gained by
the electron; (ii) inelastic tunneling (IET), where the electron
may donate or accept a quantum of energy during transfer; and
(iii) subsequently higher ordered inelastic processes (61–63). The
hypothesized presence of a possible metal cofactor site—acting
to assist either in binding or in a later activation step—at ORs,
GPCRs, and non-GPCR chemokine receptors is supported by
altered behavioral response (64–66), physiological response (66–
68), theory (69, 70), and in vitro observations (70–79).
Fig. 2. Plots of the tunneling probability as a function of energy, P(E), for
various deuterated analogues of the DOI molecule. (Top Left) In orange,
2H16 deuterated DOI; (Top Right) in green
2H18 deuterated DOI; (Bottom
Left) in magenta, 2H16 and
2H17 deuterated DOI; and (Bottom Right) in cyan,
2H16,
2H17, and 2H18 deuterated DOI. In all plots, blue is the all-protium DOI
tunneling spectrum.
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Fig. 3. Plots of the tunneling probability as a function of energy, P(E), for
various deuterated analogues of the (R)-DOI molecule with respect to the
deuteration of one or both aromatic methoxy groups. Note that the dou-
ble deuteration depletes the possible active peaks at 1,600–1,800 cm−1 by
roughly 50%, indicating that this experiment could be carried out with a
detectable effect.
Within the hypothesized protein-based ET junction, the donor
and acceptor energies are offset by a quantum of energy, ∆E . If
an electron attempts to undergo an elastic tunneling process, it
has no available acceptor site. However, if the electron is capa-
ble of losing a specific quantum of energy (to an internal mode
of a bound ligand) such that Eacceptor − Edonor = ∆E , the trans-
fer can be undertaken, activating the protein. Thus, a molecule
must both fit into the active site with the correct orientation and
have a vibrational mode capable of assisting in an IET process to
activate the protein. Working within Turin’s hypothesis, several
theoretical expansions have been undertaken to account for spe-
cific considerations of the system, including charge transfer rates
(60, 80), receptor effects (80–82), and chiral effects (83).
Block et al. (17) gave several criticisms of current modeling
approaches to the VTO; these criticisms include inappropriate
reorganization energies, not considering dynamic fluctuations on
the system, excluding possible protein electron couplings during
ET, and an unreliable electron delivery mechanism. Recently,
Reese et al. (81) addressed several of these concerns, showing
that the binding effects of the receptor have a nonzero—all but
negligible—effect on the ligand, that dynamic fluctuations have
a very small effect on the transfer, and that the reorganization
energy (λ) for an OR can conform to λ 1 kcal/mol. Concerns
of electron density leaking into the environment were previously
addressed through coupling a vibrational bath with the electron
transfer (80), and such studies have shown that environmental-
induced dissipation could enhance the vibrational signaling (82).
Evaluating the reliability of the electron delivery mechanism
cannot be addressed until the complete structure of the OR is
known and models account for all cofactors including the pos-
sible effects of perireceptor molecular species, as there is evi-
dence that NADPH and other oxidative processes are impor-
tant in GPCR activation (59). Furthermore, future theoretical
investigations should include the fundamental electron–dipole
interaction—placing emphasis on the orientation of each vibrat-
ing dipole—described by Lambe and Jaklevic (61), Kirtley et al.
(62), and Phillips and Adkins (63), among others. This interac-
tion potential permits Raman modes to assist transfer and was
recently used by Bittner et al. (84).
We—in the context of Turin’s VTO—previously conducted a
theoretical study of several ligands belonging to the family of
serotonin receptor agonists. Within this previous study, tunnel-
ing spectra were generated and a single common peak among
all of the agonists was determined; the IET probability den-
sity displayed behavior scaling with the efficacies of the ago-
nists at the 5HT2A receptor (36). Herein, we test the validity
of this vibrational theory of protein activation by examining the
assumed active peak—as determined in the above-discussed pre-
vious work (36)—at roughly 1,500–1,650 cm−1; this energy range
is also in agreement with a characteristic infrared peak for his-
tidine receptors as determined by Chee and June (33), Chee
et al. (34), and Oh (35). We have calculated the effects on the
tunneling probability of several deuterium variants for a pair of
well-characterized 5-HT2A agonists: (R)-DOI and DAM-57. The
structure of (R)-DOI can be found in Fig. 1A, hereafter referred
to as structure 1; note that the locations of the candidate deu-
terium exchanges are highlighted for ease of discussion. Simi-
larly, the structure of DAM-57, with its deuterium exchanges can
be found in Fig. 1B and is hereafter referred to as structure 2.
We have used the computational methods discussed within our
previous work (36), as first described by Turin (11, 12).
Several deuteration schemes of structure 1 were considered to
determine the scheme capable of maximizing the possible vari-
ation in efficacy at the receptor to a high enough degree that it
is unlikely to be solely attributable to the pedestrian kinetic iso-
tope effects. By deuterating the ethyl sidechain of DOI we found
that no such deuterium analogue would present sufficient change
in the agonist efficacy. The effects of deuteration on the tunnel-
ing spectrum can be seen in Fig. 2. Within each plot in Fig. 2,
the blue curve denotes the natural abundance compound and is
given as a comparison. As can be seen in Fig. 2, no deuteration
scheme of the alkyl sidechain produces a large effect on the tun-
neling spectra in the target energy region. The alteration in the
tunneling probability, and thus the tunneling current, associated
with these schemes is a decrease of roughly 10%. Although this
is a substantial difference in terms of efficacy, anything smaller
than 10% may not be convincing, as it could be attributable to
the normal causes of kinetic isotope effects. Additionally, alter-
ation of isotopes changes the vibrations, possibly highlighting a
kinetic isotope effect that may be 8–10% itself (85, 86), leading
to a further disregard of these findings.
Experimental Procedures
In Fig. 3 we have plotted the probability distribution function (PDF) for
the IET during the subsequent deuteration of one (d3), and then both (d6)
methoxy groups on the aromatic ring of DOI. Within Fig. 3, Pro-protium
DOI is shown in blue, d3 in orange, and d6 in green. Notably, d6 results in
an∼50% depletion in the assumed active peak. Such a difference should be
experimentally evident; additionally this effect would be larger than a typi-
cal kinetically derived isotope effect (85, 86). Reducing the tunneling prob-
ability would result in a much lower probability of an electron completing
a tunneling transfer assisted by vibrational modes within this energy range.
This depletion of the associated tunneling probability in a specific energy
region is attributable to two interrelated effects: (i) Isotope exchange results
in shifting of energy quanta of a specific vibrational mode. (ii) Alteration
of coupling between a vibrational mode (oscillating dipole) and an elec-
tron is dependent on the size of the dipole (displacement), and the relative
Table 1. Binding affinities of (R)-DOI and its hexadeutero
isotopologue at cloned human receptors
Ligand h5-HT2A pKi (Ki)* h5-HT2B pKi (Ki) h5-HT2C pKi (Ki)
R-DOI HCl 8.19 ± 0.09 8.71 ± 0.07 7.96 ± 0.06
(6.45) (1.95) (10.96)
R-d6-DOI HCl 8.02 ± 0.07 8.65 ± 0.07 7.99 ± 0.06
(9.52) (2.24) (10.23)
Values were determined by PDSP; n = 2 full displacement curves except
for 5-HT2A, where (R)-DOI n = 6 and (R)-d6-DOI n = 7.
*(Ki) values are expressed as nanomolar.
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Table 2. Comparison of (R)-DOI and DAM-57 and their hexadeutero isotopologues for
activation of 5-HT2A/2B/2C measuring Gq-mediated calcium flux, as illustrated in Fig. 4
Gq calcium flux
5-HT2A 5-HT2B 5-HT2C
EC50, nM Emax EC50, nM Emax EC50, nM Emax
Ligands (pEC50± SEM) % 5-HT (pEC50± SEM) % 5-HT (pEC50± SEM) % 5-HT
5-HT 0.83 100 1.29 100 0.25 100
(9.08 ± 0.02) (9.01 ± 0.12) (9.62 ± 0.10)
(R)-DOI 0.58 95 ± 4 4.80 94 ± 1 2.19 101 ± 2
(9.25 ± 0.08) (8.43 ± 0.12) (8.70 ± 0.14)
(R)-d6-DOI 0.63 96 ± 4 4.40 91 ± 1 2.23 100 ± 3
(9.22 ± 0.10) (8.45 ± 0.10) (8.70 ± 0.15)
DAM-57 1.54 98 ± 1 13.6 73 ± 2 57.5 81 ± 6
(8.82 ± 0.06) (7.87 ± 0.04) (7.24 ± 0.02)
d6-DAM-57 1.51 98 ± 1 12.6 74 ± 1 49.2 83 ± 6
(8.84 ± 0.07) (7.91 ± 0.05) (7.31 ± 0.02)
Calcium flux data were acquired with human 5-HT2A, 5-HT2B, and 5-HT2C INI-expressing tetracycline-
inducible HEK cells. Estimates of EC50 and Emax represent the average and SE of the mean (SEM) from three
independent experiments performed in triplicate. Emax is defined as percentage of 5-HT maximum response.
magnitude of an IET PDF peak associated with a mode is dependent on the
mass of an atom. This depletion of electron transfer should result in fewer
successful activations of the protein than the natural abundance compound.
It is for these reasons that the deuteration schemes involving exchange of
all six of the methoxy hydrogens of DOI and the methyl chains on the amide
of DAM-57 were selected as candidates.
d6-(R)-DOI was prepared by an asymmetric synthesis, as shown in Fig. S1.
NMR, mass spectral, and melting-point data were consistent with a pre-
viously published synthesis of the protio compound (87). d6-DAM-57 was
prepared by a standard route (Fig. S2), using either dimethylamine or d6-
dimethylamine. First, DOI and d6-DOI were submitted to the National Insti-
tute of Mental Health (NIMH)-sponsored Psychoactive Drug Screening Pro-
gram (PDSP) (88) to determine their binding affinities at the human 5-HT2A
receptor and then all compounds were tested at 5-HT2A, 5-HT2B, and 5-HT2C
receptors, measuring Gq-mediated calcium flux. A complete discussion of
the synthetic routes for all molecules, as well as a discussion of the biologi-
cal assays, is given in Supporting Information.
Results and Discussion
Herein, we operate under the following null hypothesis: A
vibration-sensitive mechanism is shared between all members
of the GPCR class of proteins, possibly due to conserved topo-
graphical structures even without conservation of sequence iden-
tities, implying that general topographical structures of the
GPCRs are essential in performing their biological task (89). Fol-
lowing this logic, it seems reasonable that the family of GPCRs
likely shares a common fundamental activation mechanism. Fur-
thermore, forms of both the lock-and-key and the glove-and-
hand models exist in olfactory research, admitting acceptance
of common aspects. Due to the likelihood of a common fun-
damental activation mechanism, findings at CNS GPCRs will
have implications at mammalian ORs. We have used a series
of well-characterized GPCRs (explicitly h5-HT2A, h5-HT2B, and
h5-HT2C) with two established ligands: (R)-DOI and DAM-57.
IET spectra were generated for both molecules, using meth-
ods prescribed by Turin in previous works (11, 12). Within a
previous work (36), we examined the IET spectrum of several
agonists and determined a consistently shared peak between the
agonist’s spectra, the area of this shared spectral aspect roughly
scaled with the agonist’s efficacy. This peak was consistent with
the works of Chee and June (33), Chee et al. (34), and Oh
(35), who attempted to generate a novel pharmacophore tool
based on shared vibrational peaks. From the candidate deuter-
ation schemes discussed above, we sought the greatest possible
alteration in efficacy at the previously suggested activation peak
to focus our experimental effort (36).
Both (R)-DOI and (R)-d6-DOI were synthesized and were
assayed for binding affinity (Table 1). All four compounds were
assayed for functional activity, using calcium flux assays (Fig.
4 and Table 2) at the 5-HT2A, 5-HT2B, and 5-HT2C receptors.
Neither (R)-d6-DOI nor d6-DAM-57 presented significant alter-
ations in either binding or potency and efficacy (as noted by EC50
and Emax , respectively) compared with the protium versions. The
endogenous agonist 5-HT was included in the calcium flux assays
for comparison.
The process of protein agonism/antagonism involves, at min-
imum, two steps: binding of the ligand to the active site of the
protein and the activation of the protein. It should be noted that
these actions may happen in concert as proposed in the hand-in-
glove/multiconformation (5–8) models or as two individual steps
(11, 60, 67, 80, 90). In Table 1, we present the results of bind-
ing displacement assays comparing the relative binding affinity
of both (R)-DOI and (R)-d6-DOI at several serotonin GPCRs.
Alteration in the binding kinetics, as defined by pKi, shows no sig-
nificant difference between the protonated and deuterated vari-
ants; explicitly, any difference found in the power-scaled equilib-
rium constant exists within the standard errors of the number, and
therefore no claim of a difference can be made with confidence.
The kinetic isotope effect may also affect the binding kinetics of
the G protein and thus could appear independently of ligand-
binding effects but would be apparent in activation studies.
Fig. 4. Calcium flux responses at human 5-HT2A, 5-HT2B, and 5-HT2C
INI receptors for (R)-DOI (red), (R)-d6-DOI (orange), DAM-57 (blue), and
d6-DAM-57 (purple). Data are representative at each receptor type per-
formed in triplicate and in parallel.
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Activation analysis was conducted through a series of exper-
iments at human tetracycline-inducible HEK cells expressing
all members of the h5-HT2 receptor subclass. Receptor acti-
vation was determined by calcium flux assay, dependent on
Gαq dissociation. The experiment was performed in triplicate
(n = 3) to achieve relevant statistics. Results of the Gαq flux
can be found in both Fig. 4 and Table 2 for five species. It
is clear from Fig. 4 that DOI is a near full agonist at all
three 5-HT2 receptors examined in this assay, whereas DAM-57
shows partial agonist activity at 5-HT2B and 5-HT2C receptors.
Additionally—and more prescient—there is no significant differ-
ence in calcium flux between either pair of parent–isotopologue
compounds at any of the 5-HT2 receptors. This conclusion is
illustrated in Table 2, which gives both the EC50 and the per-
centage of Emax . The power-scaled pEC50, which estimates dif-
ferences in potency between each pair of parent–isotopologue
compounds, is within the SE and likewise for the percentage of
maximum response (where 100% is taken to be the response to
the endogenous 5-HT ligand). Therefore, no significant ligand-
binding or activation (due to either ligand–receptor or ligand–
receptor-G protein interactions) effects were found.
Herein, we found no exceptional dependency on isotopic
exchange for the activity of either (R)-DOI or DAM-57. These
findings do not argue for the irrelevancy of isotopic exchange,
but do relegate the majority of this concern to binding. Isotope
effects on the binding of a ligand with a protein have been exam-
ined extensively (85, 86) and were the subject of a recent paper
on the H2 histamine receptor (58). Whereas Krzˇan et al. (58)
detected small alterations in the binding of ligand to receptor due
to isotope exchange and conclude with possibly relevant com-
ments concerning the VTO, we considered both the affinity and
the functional activity. By considering both aspects, we are able
to draw conclusions regarding the activation of the protein—
addressing the VTO directly—while retaining knowledge of pos-
sible binding effects. As this work was to evaluate the depen-
dency of activation on vibrational modes of ligands in GPCRs
within the CNS through an IET-esque mechanism, we state that
we found no evidence suggestive of the plausibility of said theory.
We believe that the findings within this paper argue very strongly
against the VTO. Furthermore, this places our work in agree-
ment with the transition state theories (recent works: refs. 5–8).
Physiochemical properties of the ligand—other than vibrational
quanta—are likely involved in the activation of both ORs—as
suggested for Drosophila receptors by Saberi and Seyed-allaei
(91)—and GPCRs in general.
Conclusion
Herein, we attempted to examine the viability of a contentious
theory of protein activation—originally proposed for ORs—with
a series of serotonin receptors widely expressed in the CNS:
h5-HT2A, h5-HT2B, and h5-HT2C. We have tested two well-
characterized ligands—and specific isotopologues—at the 5-HT
receptor family: (R)-DOI and DAM-57. Our calculations of
the tunneling probability—based on Turin’s theory—predicted
as much as a 50% loss of potency for both (R)-d6-DOI and
d6-DAM-57, compared with their protium counterparts. The
minor deviations in the binding between (R)-DOI and (R)-d6-
DOI were within the SE and therefore cannot be assumed to be
of any significance, as were the changes in receptor function mea-
sured by calcium flux. Similarly, no deviation in the potency or
efficacy was detected for d6-DAM-57. As all values were within
the SE, we can only conclude that alteration of the hydrogen iso-
topes at (R)-DOI and DAM-57 agonists has no significant effect
on the activity at the series of 5-HT receptors studied herein.
Clearly, our results are not consistent with predictions made
under the VTO acting within nonolfactory GPCRs. This calls
into question the viability of the IET mechanism within non-OR
GPCRs, while additionally making it more difficult to argue in
favor of the VTO without invoking exceptionalism of ORs within
the GPCR class of proteins.
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